Gonadotrophin replacement for induction of fertility in hypogonadal men

被引：72
|
作者：
Dwyer, Andrew A. [1 ]
Raivio, Taneli [2 ,3 ]
Pitteloud, Nelly [1 ,4 ]
机构：
[1] CHU Vaudois, Endocrinol Diabet & Metab Serv, CH-1011 Lausanne, Switzerland
[2] Univ Helsinki, Inst Biomed Physiol, Helsinki, Finland
[3] Helsinki Univ Cent Hosp, Childrens Hosp, Helsinki, Finland
[4] Univ Lausanne, Fac Biol & Med, CHU Vaudois, Inst Physiol & Endocrinol,Diabet & Metab Serv, CH-1011 Lausanne, Switzerland
来源：
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM | 2015年 / 29卷 / 01期
关键词：
GnRH deficiency; Kallmann syndrome; hypogonadotrophic hypogonadism; male fertility; gonadotrophin therapy; fertility treatment; fertility outcomes; HUMAN CHORIONIC-GONADOTROPIN; FOLLICLE-STIMULATING-HORMONE; INTRACYTOPLASMIC SPERM INJECTION; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT HUMAN FSH; ANTIMULLERIAN HORMONE; LUTEINIZING-HORMONE; KALLMANN-SYNDROME; MALE-INFERTILITY; AZOOSPERMIC MEN;
D O I：
10.1016/j.beem.2014.10.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Congenital hypogonadotrophic hypogonadism (CHH) is a rare form of infertility caused by deficient secretion or action of gonadotrophin-releasing hormone. There is no consensus regarding the optimal approach to fertility treatment in CHH men. In most cases, appropriate hormonal treatment with human chorionic gonadotrophin with or without follicle stimulating hormone will induce testicular development, spermatogenesis and fertility. Recent studies have examined sequential treatment with FSH pretreatment to optimize fertility outcomes in severely affected CHH patients. This paper reviews historical and recent literature to summarize the current evidence on therapeutic approaches for CHH men seeking fertility. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码：91 / 103
页数：13
相关论文
共 50 条
  • [1] Fertility induction in hypogonadotropic hypogonadal men
    Prior, Matthew
    Stewart, Jane
    McEleny, Kevin
    Dwyer, Andrew A.
    Quinton, Richard
    CLINICAL ENDOCRINOLOGY, 2018, 89 (06) : 712 - 718
  • [2] URINARY GONADOTROPHIN EXCRETION IN HYPOGONADAL MEN
    HUTCHINS.JS
    WORDEN, JM
    PRUNTY, FTG
    JOURNAL OF ENDOCRINOLOGY, 1965, 32 (02) : 237 - &
  • [3] Fertility Considerations in Hypogonadal Men
    Papanikolaou, Nikoleta
    Jayasena, Channa N.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2022, 51 (01) : 133 - 148
  • [4] CLOMIPHENE CITRATE AND HUMAN CHORIONIC GONADOTROPHIN ARE GOOD ALTERNATIVE THERAPY TO TESTESTERONE IN HYPOGONADAL MEN SEEKING FERTILITY
    Habous, M.
    Elhadek, W.
    Shamndy, M.
    Mahmoud, S.
    Abdelwahab, O.
    Abdelrahman, Z.
    Muir, G.
    Mulhall, J.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 56 - 56
  • [5] Testosterone Replacement Therapy in Hypogonadal Men
    Wang, Christina
    Swerdloff, Ronald S.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2022, 51 (01) : 77 - 98
  • [6] Effects of testosterone replacement in hypogonadal men
    Snyder, PJ
    Peachey, H
    Berlin, JA
    Hannoush, P
    Haddad, G
    Dlewati, A
    Santanna, J
    Loh, L
    Lenrow, DA
    Holmes, JH
    Kapoor, SC
    Atkinson, LE
    Strom, BL
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (08): : 2670 - 2677
  • [7] Update on Testosterone Replacement Therapy in Hypogonadal Men
    Leung, Kevin Matthew Yen Bing
    Alrabeeah, Khalid
    Carrier, Serge
    CURRENT UROLOGY REPORTS, 2015, 16 (08)
  • [8] Update on Testosterone Replacement Therapy in Hypogonadal Men
    Kevin Matthew Yen Bing Leung
    Khalid Alrabeeah
    Serge Carrier
    Current Urology Reports, 2015, 16
  • [9] Current topics in testosterone replacement of hypogonadal men
    Nieschlag, Eberhard
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 29 (01) : 77 - 90
  • [10] Management of Male Fertility in Hypogonadal Patients on Testosterone Replacement Therapy
    Fink, Julius
    Ide, Hisamitsu
    Horie, Shigeo
    MEDICINA-LITHUANIA, 2024, 60 (02):
12345